|
[1]
|
Belmont, H.M., Abramson, S.B. and Lie, J.T. (1996) Pathology and Pathogenesis of Vascular Injury in Systemic Lupus Erythematosus. Interactions of Inflammatory Cells and Activated Endothelium. Arthritis Rheumatology, 39, 9-22.
http://dx.doi.org/10.1002/art.1780390103
|
|
[2]
|
Hanly, J.G., Walsh, N.M. and Sangalang, V. (1992) Brain Pathology in Systemic Lupus Erythematosus. Journal of Rheumatology, 19, 732-741.
|
|
[3]
|
Abbott, N.J., Mendonca, L.L. and Dolman, D.E. (2003) The Blood-Brain Barrier in Systemic Lupus Erythematosus. Lupus, 12, 908-915.
http://dx.doi.org/10.1191/0961203303lu501oa
|
|
[4]
|
Devreese, K.M. (2012) Standardization of Antiphospholipid Antibody Assays. Where Do We Stand? Lupus, 21, 718-721.
http://dx.doi.org/10.1177/0961203312439335
|
|
[5]
|
Kent, M., Alvarez, F., Vogt, E., Fyffe, R., Ng, A.K. and Rote, N. (1997) Monoclonal Antiphosphatidylserine Antibodies React Directly with Feline and Murine Central Nervous System. Journal of Rheumatology, 24, 1725-1733.
|
|
[6]
|
Shoenfeld, Y., Nahum, A., Korczyn, A.D., Dano, M., Rabinowitz, R., Beilin, O., et al. (2003) Neuronal-Binding Antibodies from Patients with Antiphospholipid Syndrome Induce Cognitive Deficits Following Intrathecal Passive Transfer. Lupus, 12, 436-442.
http://dx.doi.org/10.1191/0961203303lu409oa
|
|
[7]
|
Caronti, B., Calderaro, C., Alessandri, C., Conti, F., Tinghino, R., Pini, C., et al. (1998) Serum Anti-Beta2-Glycoprotein I Antibodies from Patients with Antiphospholipid Antibody Syndrome Bind Central Nervous System Cells. Journal of Autoimmunity, 11, 425-429.
http://dx.doi.org/10.1006/jaut.1998.0214
|
|
[8]
|
Caronti, B., Pittoni, V., Palladini, G. and Valesini, G. (1998) Anti-Beta 2-Glycoprotein I Antibodies Bind to Central Nervous System. Journal of Neuroscience, 156, 211-219.
|
|
[9]
|
Denburg, S.D., Carbotte, R.M. and Denburg, J.A. (1987) Cognitive Impairment in Systemic Lupus Erythematosus: A Neuropsychological Study of Individual and Group Deficits. Journal of Clinical and Experimental Neuropsychology, 9, 323-339.
http://dx.doi.org/10.1080/01688638708405054
|
|
[10]
|
Hanly, J.G., Robichaud, J. and Fisk, J.D. (2006) Anti-NR2 Glutamate Receptor Antibodies and Cognitive Function in Systemic Lupus Erythematosus. Journal of Rheumatology, 33, 1553-1558.
|
|
[11]
|
Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., et al. (2003) Morbidity and Mortality in Systemic Lupus Erythematosus during a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1, 000 Patients. Medicine, 82, 299-308.
http://dx.doi.org/10.1097/01.md.0000091181.93122.55
|
|
[12]
|
Hanly, J.G., Hong, C., Smith, S. and Fisk, J.D. (1999) A Prospective Analysis of Cognitive Function and Anticardiolipin Antibodies in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 42, 728-734.
http://dx.doi.org/10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O
|
|
[13]
|
Menon, S., Jameson-Shortall, E., Newman, S.P., Hall-Craggs, M.R., Chinn, R. and Isenberg, D.A. (1999) A Longitudinal Study of Anticardiolipin Antibody Levels and Cognitive Functioning in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 42, 735-741.
http://dx.doi.org/10.1002/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L
|
|
[14]
|
Shah, N.M., Khamashta, M.A., Atsumi, T. and Hughes, G.R. (1998) Outcome of Patients with Anticardiolipin Antibodies: A 10 Year Follow-Up of 52 Patients. Lupus, 7, 3-6.
http://dx.doi.org/10.1191/096120398678919624
|
|
[15]
|
Toubi, E., Khamashta, M.A., Panarra, A. and Hughes, G.R. (1995) Association of Antiphospholipid Antibodies with Central Nervous System Disease in Systemic Lupus Erythematosus. The American Journal of Medicine, 99, 397-401.
http://dx.doi.org/10.1016/S0002-9343(99)80188-0
|
|
[16]
|
Rodriguez, A.S., Oterino, J.A. and Hernandez, P.A. (1998) Lupus Myelitis. Archives of Internal Medicine, 158, 2267-2268.
http://dx.doi.org/10.1001/archinte.158.20.2267
|
|
[17]
|
Borowoy, A.M., Pope, J.E., Silverman, E., Fortin, P.R., Pineau, C., Smith, C.D., et al. (2012) Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort. Seminars in Arthritis and Rheumatism, 42, 179-185.
http://dx.doi.org/10.1016/j.semarthrit.2012.03.011
|
|
[18]
|
Bluestein, H.G., Williams, G.W. and Steinberg, A.D. (1981) Cerebrospinal Fluid Antibodies to Neuronal Cells: Association with Neuropsychiatric Manifestations of Systemic Lupus Erythematosus. The American Journal of Medicine, 70, 240-246.
http://dx.doi.org/10.1016/0002-9343(81)90756-7
|
|
[19]
|
Isshi, K. and Hirohata, S. (1998) Differential Roles of the Anti-Ribosomal P Antibody and Antineuronal Antibody in the Pathogenesis of Central Nervous System Involvement in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 41, 1819-1827.
http://dx.doi.org/10.1002/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y
|
|
[20]
|
Winfield, J.B., Brunner, C.M. and Koffler, D. (1978) Serologic Studies in Patients with Systemic Lupus Erythematosus and Central Nervous System Dysfunction. Arthritis & Rheumatism, 21, 289-294.
http://dx.doi.org/10.1002/art.1780210301
|
|
[21]
|
Yasuma, M., Takasaki, Y., Matsumoto, K., Kodama, A., Hashimoto, H. and Hirose, S. (1990) Clinical Significance of IgG Anti-Sm Antibodies in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology, 17, 469-475.
|
|
[22]
|
Hirohata, S. and Kosaka, M. (1994) Association of Anti-Sm Antibodies with Organic Brain Syndrome Secondary to Systemic Lupus Erythematosus. The Lancet, 343, 796.
http://dx.doi.org/10.1016/S0140-6736(94)91875-9
|
|
[23]
|
Hirohata, S., Sakuma, Y., Yanagida, T. and Yoshio, T. (2014) Association of Cerebrospinal Fluid Anti-Sm Antibodies with Acute Confusional State in Systemic Lupus Erythematosus. Arthritis Research & Therapy, 16, 450.
http://dx.doi.org/10.1186/s13075-014-0450-z
|
|
[24]
|
Sato, T., Fujii, T., Yokoyama, T., Fujita, Y., Imura, Y., Yukawa, N., et al. (2010) Anti-U1 RNP Antibodies in Cerebrospinal Fluid Are Associated with Central Neuropsychiatric Manifestations in Systemic Lupus Erythematosus and Mixed Connective Tissue Disease. Arthritis Research & Therapy, 62, 3730-3740.
http://dx.doi.org/10.1002/art.27700
|
|
[25]
|
Santer, D.M., Yoshio, T., Minota, S., Moller, T. and Elkon, K.B. (2009) Potent Induction of IFN-α and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus. The Journal of Immunology, 182, 1192-1201.
http://dx.doi.org/10.4049/jimmunol.182.2.1192
|
|
[26]
|
Furukawa, H., Singh, S.K., Mancusso, R. and Gouaux, E. (2005) Subunit Arrangement and Function in NMDA Receptors. Nature, 438, 185-192.
http://dx.doi.org/10.1038/nature04089
|
|
[27]
|
De Giorgio, L.A., Konstantinov, K.N., Lee, S.C., Hardin, J.A., Volpe, B.T. and Diamond, B. (2001) A Subset of Lupus Anti-DNA Antibodies Cross-Reacts with the NR2 Glutamate Receptor in Systemic Lupus Erythematosus. Nature Medicine, 7, 1189-1193.
http://dx.doi.org/10.1038/nm1101-1189
|
|
[28]
|
Kowal, C., De Giorgio, L.A., Nakaoka, T., Hetherington, H., Huerta, P.T., Diamond, B., Volpe, B.T., et al. (2004) Cognition and Immunity: Antibody Impairs Memory. Immunity, 21, 179-188.
http://dx.doi.org/10.1016/j.immuni.2004.07.011
|
|
[29]
|
Husebye, E.S., Sthoeger, Z.M., Dayan, M., Zinger, H., Elbirt, D., Levite, M., et al. (2005) Autoantibodies to a NR2A Peptide of the Glutamate/NMDA Receptor in Sera of Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 64, 1210-1213.
http://dx.doi.org/10.1136/ard.2004.029280
|
|
[30]
|
Omdal, R., Brokstad, K., Waterloo, K., Koldingsnes, W., Jonsson, R. and Mellgren, S.I. (2005) Neuropsychiatric Disturbances in SLE Are Associated with Antibodies Against NMDA Receptors. European Journal of Neurology, 12, 392-398.
http://dx.doi.org/10.1111/j.1468-1331.2004.00976.x
|
|
[31]
|
Yoshio, T., Onda, K., Nara, H. and Minota, S. (2006) Association of IgG Anti-NR2 Glutamate Receptor Antibodies in Cerebrospinal Fluid with Neuropsychiatric Systemic Lupus Erythematosus. Arthritis & Rheumatism, 54, 675-678.
http://dx.doi.org/10.1002/art.21547
|
|
[32]
|
Arinuma, Y., Yanagida, T. and Hirohata, S. (2008) Association of Cerebrospinal Fluid Anti-NR2 Glutamate Receptor Antibodies with Diffuse Neuropsychiatric Systemic Lupus Erythematosus. Arthritis & Rheumatism, 58, 1130-1135.
http://dx.doi.org/10.1002/art.23399
|
|
[33]
|
Nojima, Y., Minota, S., Yamda, A., Takaku, F., Aotsuka, S. and Yokohari, R. (1992) Correlation of Antibodies to Ribosomal P Protein with Psychosis in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 51, 1053-1055.
http://dx.doi.org/10.1136/ard.51.9.1053
|
|
[34]
|
Schneebaum, A.B., Singleton, J.D., West, S.G., Blodgett, J.K., Allen, L.G., Cheronis, J.C., et al. (1991) Association of Psychiatric Manifestations with Antibodies to Ribosomal P Proteins in Systemic Lupus Erythematosus. The American Journal of Medicine, 90, 54-62.
http://dx.doi.org/10.1016/0002-9343(91)90506-S
|
|
[35]
|
Teh, L.S., Bedwell, A.E., Isenberg, D.A., Gordon, C., Emery, P., Charles, P.J., et al. (1992) Antibodies to Protein P in Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 51, 489-494.
http://dx.doi.org/10.1136/ard.51.4.489
|
|
[36]
|
Georgescu, L., Mevorach, D., Arnett, F.C., Reveille, J.D. and Elkon, K.B. (1997) Anti-P Antibodies and Neuropsychiatric Lupus Erythematosus. Annals of the New York Academy of Sciences, 823, 263-269.
http://dx.doi.org/10.1111/j.1749-6632.1997.tb48399.x
|
|
[37]
|
Karassa, F.B., Afeltra, A., Ambrozic, A., Chang, D.M., De Keyser, F., Doria, A., et al. (2006) Accuracy of Anti-Ribosomal P Protein Antibody Testing for the Diagnosis of Neuropsychiatric Systemic Lupus Erythematosus: An International Meta-Analysis. Arthritis & Rheumatism, 54, 312-314.
http://dx.doi.org/10.1002/art.21539
|
|
[38]
|
Katzav, A., Solodeev, I., Brodsky, O., Chapman, J., Pick, C.G., Blank, M., et al. (2007) Induction of Autoimmune Depression in Mice by Anti-Ribosomal P Antibodies via the Limbicsystem. Arthritis & Rheumatism, 56, 938-948.
http://dx.doi.org/10.1002/art.22419
|
|
[39]
|
Matus, S., Burgos, P.V., Bravo-Zehnder, M., Kraft, R., Porras, O.H., Farías, P., et al. (2007) Antiribosomal-P Autoantibodies from Psychiatric Lupus Target a Novel Neuronal Surface Protein Causing Calcium Influx and Apoptosis. The Journal of Experimental Medicine, 204, 3221-3234.
http://dx.doi.org/10.1084/jem.20071285
|
|
[40]
|
Bravo-Zehnder, M., Toledo, E.M., Segovia-Miranda, F., Serrano, F.G., Benito, M.J., Metz, C., et al. (2015) Anti-Ribosomal P Protein Autoantibodies from Neuropsychiatric Lupus Impair Memory. Arthritis & Rheumatology, 67, 204-214.
http://dx.doi.org/10.1002/art.38900
|
|
[41]
|
Yoshio, T., Hirata, D., Onda, K., Nara, H. and Minota, S. (2005) Antiribosomal P Protein Antibodies in Cerebrospinal Fluid Are Associated with Neuropsychiatric Systemic Lupus Erythematosus. The Journal of Rheumatology, 32, 34-39.
|
|
[42]
|
Williams Jr., R.C., Sugiura, K. and Tan, E.M. (2004) Antibodies to Microtubule-Associated Protein 2 in Patients with Neuropsychiatric Systemic Lupus Erythematosus. Arthritis & Rheumatism, 50, 1239-1247.
http://dx.doi.org/10.1002/art.20156
|
|
[43]
|
Lefranc, D., Launay, D., Dubucquoi, S., de Seze, J., Dussart, P., Vermersch, M., et al. (2007) Characterization of Discriminant Human Brain Antigenic Targets in Neuropsychiatric Systemic Lupus Erythematosus Using an Immunoproteomic Approach. Arthritis & Rheumatism, 56, 3420-3432.
http://dx.doi.org/10.1002/art.22863
|
|
[44]
|
Yoshio, T., Okamoto, H., Hirohata, S. and Minota, S. (2013) IgG Anti-NR2 Glutamate Receptor Autoantibodies from Patients with Systemic Lupus Erythematosus Activate Endothelial Cells. Arthritis & Rheumatism, 65, 457-463.
http://dx.doi.org/10.1002/art.37745
|
|
[45]
|
Conti, F., Alessandri, C., Bompane, D., Bombardieri, M., Spinelli, F.R., Rusconi, A.C., et al. (2004) Autoantibody Profile in Systemic Lupus Erythematosus with Psychiatric Manifestations: A Role for Anti-Endothelial-Cell Antibodies. Arthritis Research & Therapy, 6, R366-R372.
http://dx.doi.org/10.1186/ar1198
|
|
[46]
|
Oosting, J.D., Preissner, K.T., Derksen, R.H. and de Groot, P.G. (1993) Autoantibodies Directed Against the Epidermal Growth Factor-Like Domains of Thrombomodulin Inhibit Protein C Activation in Vitro. British Journal of Haematology, 85, 761-768.
http://dx.doi.org/10.1111/j.1365-2141.1993.tb03220.x
|
|
[47]
|
Nara, H., Okamoto, H., Minota, S. and Yoshio, T. (2006) Mouse Monoclonal Anti-Human Thrombomodulin Antibodies Bind to and Activate Endothelial Cells Through NF-κB Activation in Vitro. Arthritis & Rheumatism, 54, 1629-1637.
http://dx.doi.org/10.1002/art.21797
|
|
[48]
|
Wong, D., Dorovini-Zis, K. and Vincent, S.R. (2004) Cytokines, Nitric Oxide, and cGMP Modulate the Permeability of an in Vitro Model of the Human Blood-Brain Barrier. Experimental Neurology, 190, 446-455.
http://dx.doi.org/10.1016/j.expneurol.2004.08.008
|
|
[49]
|
Shiozawa, S., Kuoroki, Y., Kim, M., Hirohata, S. and Ogino, T. (1992) Interferon-Alpha in Lupus Psychosis. Arthritis & Rheumatism, 35, 417-422.
http://dx.doi.org/10.1002/art.1780350410
|
|
[50]
|
Lovgren, T., Eloranta, M.L., Bave, U., Alm, G.V. and Ronnblom, L. (2004) Induction of Interferon-Production in Plasmacytoid Dendritic Cells by Immune Complexes Containing Nucleic Acid Released by Necrotic or Late Apoptotic Cells and Lupus IgG. Arthritis & Rheumatism, 50, 1861-1872.
http://dx.doi.org/10.1002/art.20254
|
|
[51]
|
Martin, D.A. and Elkon, K.B. (2005) Autoantibodies Make a U-Turn: The Toll Hypothesis for Autoantibody Specificity. The Journal of Experimental Medicine, 202, 1465-1469.
http://dx.doi.org/10.1084/jem.20052228
|
|
[52]
|
Marshak-Rothstein, A. and Rifkin, I.R. (2007) Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease. Annual Review of Immunology, 25, 419-441.
http://dx.doi.org/10.1146/annurev.immunol.22.012703.104514
|
|
[53]
|
Yoshio, T., Okamoto, H., Kurasawa, K., Dei, Y., Hirohata, S. and Minota, S. (2013) The Presence of IgG-Immune Complexes in the Cerebrospinal Fluids Is Associated with Central Neurocychiatricmanifestatin but Not with Intrathecal Production of Proimmflammatory Cytokines/Chemokines Such as Interferon-α in Systemic Lupus Erythematosus. Arthritis & Rheumatism, 65, S1593.
|
|
[54]
|
Trysberg, E., Carlsten, H. and Tarkowski, A. (2000) Intrathecal Cytokines in Systemic Lupus Erythematosus with Central Nervous System Involvement. Lupus, 9, 498-503.
http://dx.doi.org/10.1177/096120330000900704
|
|
[55]
|
Svenungsson, E., Andersson, M., Brundin, L.,van Vollenhoven, R., Khademi, M., Tarkowski, A., et al. (2001) Increased Levels of Proinflammatory Cytokines and Nitric Oxide Metabolites in Neuropsychiatric Lupus Erythematosus. Annals of the Rheumatic Diseases, 60, 372-379.
http://dx.doi.org/10.1136/ard.60.4.372
|
|
[56]
|
Iikuni, N., Okamoto, H., Yoshio, T., Sato, E., Kamitsuji, S., Iwamoto, T., et al. (2006) Raised Monocyte Chemotactic Protein-1 (MCP-1)/CCL2 in Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus. Annals of the Rheumatic Diseases, 65, 253-256.
http://dx.doi.org/10.1136/ard.2005.041640
|
|
[57]
|
Okamoto, H., Iikuni, N., Kamitsuji, S., Yoshio, T., Minota, S. and Kamatani, N. (2006) IP-10/MCP-1 Ratio in CSF Is an Useful Diagnostic Marker of Neuropsychiatric Lupus Patients. Rheumatology, 45, 232-234.
http://dx.doi.org/10.1093/rheumatology/kei233
|
|
[58]
|
Okamoto, H., Katsumata, Y., Nishimura, K. and Kamatani, N. (2004) Interferon-Inducible Protein 10/CXCL10 Is Increased in the Cerebrospinal Fluid of Patients with Central Nervous System Lupus. Arthritis & Rheumatism, 50, 3731-3732.
http://dx.doi.org/10.1002/art.20598
|
|
[59]
|
Yoshio, T., Okamoto, H., Kurasawa, K., Dei, Y., Hirohata, S. and Minota, S. (2011) The Intrathecal Production of IL-6, IL-8, IP-10, MCP-1 and G-CSF Increases More Highly Than the Serum Production in Patients with Central Neuropsychiatric Lupus Erythematosus. Arthritis & Rheumatism, 63, S1711.
|
|
[60]
|
Matsushita, T., Tateishi, T., Isobe, N., Yonekawa, T., Yamasaki, R., Matsuse, D., et al. (2013) Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitisoptica, Relapsing Remitting or Primary Progressive Multiple Sclerosis. PLoS ONE, 8, e61835.
http://dx.doi.org/10.1371/journal.pone.0061835
|
|
[61]
|
Schneider, A., Kruger, C., Steigleder, T., Weber, D., Pitzer, C., Laage, R., et al. (2005) The Hematopoietic Factor G-CSF Is a Neuronal Ligand That Counteracts Programmed Cell Death and Drives Neurogenesis. The Journal of Clinical Investigation, 115, 2083-2098.
http://dx.doi.org/10.1172/JCI23559
|
|
[62]
|
Pitzer, C., Krüger, C., Plaas, C., Kirsch, F., Dittgen, T., Müller, R., et al. (2008) Granulocyte-Colony Stimulating Factor Improves Outcome in a Mouse Model of Amyotrophic Lateral Sclerosis. Brain, 131, 3335-3347.
http://dx.doi.org/10.1093/brain/awn243
|
|
[63]
|
Hirohata, S., Arinuma, Y., Takayama, M. and Yoshio, T. (2007) Association of Cerebrospinal Fluid Anti-Ribosomal P Protein Antibodies with Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus. Arthritis Research & Therapy, 9, R44.
http://dx.doi.org/10.1186/ar2184
|
|
[64]
|
Fancellu, R., Pareyson, D., Corsini, E., Salsano, E., Laura?, M., Bernardi, G., et al. (2009) Immunological Reactivity against Neuronal and Non-Neuronal Antigens in Sporadic Adult-Onset Cerebellar Ataxia. European Neurology, 62, 356-361.
http://dx.doi.org/10.1159/000242010
|
|
[65]
|
Disanto, G., Morahan, J.M., Barnett, M.H., Giovannoni, G. and Ramagopalan, S.V. (2012) Theevidence for a Role of B Cells in Multiple Sclerosis. Neurology, 78, 823-832.
http://dx.doi.org/10.1212/WNL.0b013e318249f6f0
|